Menu Close

Digexin® Clinical Studies

Digexin is backed by human research including open label and placebo comparison studies with results showing improved digestion and enhanced mood.

The initial randomized, double-blind, placebo-controlled clinical trial evaluated the efficacy and tolerability of Digexin to relieve constipation and improve bowel clearance over 14 days. Forty-eight healthy male and female participants, age 25 to 60, were assigned to one of three study arms: 300mg of Digexin, 500 mg of Digexin, or placebo.

female-hand-typing-keyboard-laptop

Self-administered questionnaires were assessed and revealed both doses:

  • Reduced constipation symptoms
  • Improved sense of complete evacuation
  • Improved quality of life based on significantly reducing physical and psychological discomfort, worries, and concerns
  • Improved sleep quality

NXT USA is in search of early-stage partners to start the process of creating finished products. Further, a second larger clinical trial is currently underway to help validate Digexin’s benefits.

*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

test
nutraceutical_world
vegan icon 2

Digexin® News

NXT USA, a new company developing unique nutraceutical solutions, is launching a novel digestive health solution called Digexin at SupplySide West.

Backed by a new human proof-of-concept study showing improved digestion and enhanced mood, NXT USA is in search of early-stage partners to start the process of creating finished products.